Floatz logo

Therapeutic Asset Ratings

3,272 results matching 1 filter

91,564 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Ulixertinib
Ependymoma
National Cancer Institute (NCI)P2CCC (53)
Ulixertinib
Ewing Sarcoma
National Cancer Institute (NCI)P2CCC (53)
Ulixertinib
Glioma
National Cancer Institute (NCI)P2CCC (53)
Ulixertinib
Hepatoblastoma
National Cancer Institute (NCI)P2CCC (53)
Ulixertinib
Histiocytic And Dendritic Cell Neoplasm
National Cancer Institute (NCI)P2CCC (53)
Ulixertinib
Malignant Germ Cell Tumor
National Cancer Institute (NCI)P2CCC (53)
Ulixertinib
Medulloblastoma
National Cancer Institute (NCI)P2CCC (53)
Ulixertinib
Neuroblastoma
National Cancer Institute (NCI)P2CCC (53)
Ulixertinib
Osteosarcoma
National Cancer Institute (NCI)P2CCC (53)
Ulixertinib
Peripheral Primitive Neuroectodermal Tumor
National Cancer Institute (NCI)P2CCC (53)
Ulixertinib
Central Nervous System Neoplasm
National Cancer Institute (NCI)P2CCC (53)
Ulixertinib
Central Nervous System Cancer
National Cancer Institute (NCI)P2CCC (53)
Ulixertinib
Rhabdoid Tumor
National Cancer Institute (NCI)P2CCC (53)
Ulixertinib
Skin Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Ulixertinib
Soft Tissue Sarcoma
National Cancer Institute (NCI)P2CCC (53)
Ulixertinib
Thyroid Gland Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Ulixertinib
Refractory Malignant Neoplasm
National Cancer Institute (NCI)P2CCC (53)
Ulixertinib
Wilms Tumor
National Cancer Institute (NCI)P2CCC (53)
Uprosertib
Uveal Melanoma
National Cancer Institute (NCI)P2CCC (53)
Veliparib
Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative
National Cancer Institute (NCI)P2CCC (53)
Veliparib
Malignant Glioma
National Cancer Institute (NCI)P2CCC (53)
Veliparib
Myelodysplastic/Myeloproliferative Neoplasm
National Cancer Institute (NCI)P2CCC (53)
Venetoclax
Acute Myeloid Leukemia With Multilineage Dysplasia
National Cancer Institute (NCI)P2CCC (53)
Venetoclax
Core Binding Factor Acute Myeloid Leukemia
National Cancer Institute (NCI)P2CCC (53)
Venetoclax
Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type
National Cancer Institute (NCI)P2CCC (53)
Showing 2151 to 2175 of 3,272 assets
PreviousPage 87 of 131Next